Muscarinic Receptors and Alzheimer's Disease: New Perspectives and Mechanisms

被引:2
|
作者
Monaco, Martina [1 ]
Trebesova, Hanna [1 ]
Grilli, Massimo [1 ,2 ]
机构
[1] Univ Genoa, Dept Pharm, Viale Cembrano 4, I-16148 Genoa, Italy
[2] Interuniv Ctr Promot 3Rs Principles Teaching & Res, I-16148 Genoa, Italy
关键词
Alzheimer's disease; muscarinic receptors; cholinergic transmission; neuroinflammation; innovative therapy; ACETYLCHOLINE-RECEPTOR; BINDING; DEFICITS; AGONIST; MEMORY; MODEL; NEUROINFLAMMATION; EXPRESSION; AROUSAL; PROTEIN;
D O I
10.3390/cimb46070407
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases on a global scale. Historically, this pathology has been linked to cholinergic transmission, and despite the scarcity of effective therapies, numerous alternative processes and targets have been proposed as potential avenues for comprehending this complex illness. Nevertheless, the fundamental pathophysiological mechanisms underpinning AD remain largely enigmatic, with a growing body of evidence advocating for the significance of muscarinic receptors in modulating the brain's capacity to adapt and generate new memories. This review summarizes the current state of the art in the field of muscarinic receptors' involvement in AD. A specific key factor was the relationship between comorbidity and the emergence of new mechanisms.
引用
收藏
页码:6820 / 6835
页数:16
相关论文
共 50 条
  • [1] Muscarinic receptors and Alzheimer's disease
    Avila, Jesus
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2011, 1 (04) : 267 - 269
  • [2] On the physiological relevance of muscarinic acetylcholine receptors in Alzheimer's disease
    Koch, HJ
    Haas, S
    Jürgens, T
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (24) : 2915 - 2921
  • [3] Glutamate Receptors in Alzheimer's Disease: Mechanisms and Therapies
    Anggono, Victor
    Tsai, Li-Huei
    Goetz, Juergen
    NEURAL PLASTICITY, 2016, 2016
  • [4] Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: Effect of tacrine treatment
    Nordberg, A
    Lundqvist, H
    Hartvig, P
    Andersson, J
    Johansson, M
    HellstromLindahl, E
    Langstrom, B
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1997, 8 (02) : 78 - 84
  • [5] New Perspectives on Alzheimer's Disease and Nutrition
    Gustafson, Deborah R.
    Morris, Martha Clare
    Scarmeas, Nikolaos
    Shah, Raj C.
    Sijben, John
    Yaffe, Kristine
    Zhu, Xiongwei
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 46 (04) : 1111 - 1127
  • [6] Alzheimer's disease: perspectives for the new millennium
    Sisodia, SS
    JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (09): : 1169 - 1170
  • [7] Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease
    Piggott, MA
    Owens, J
    O'Brien, J
    Colloby, S
    Fenwick, J
    Wyper, D
    Jaros, E
    Johnson, M
    Perry, RH
    Perry, EK
    JOURNAL OF CHEMICAL NEUROANATOMY, 2003, 25 (03) : 161 - 173
  • [8] Alzheimer's Disease: From Molecular Mechanisms to Psychobiological Perspectives
    Kamal, Mohammad A.
    Greig, Nigel H.
    CURRENT ALZHEIMER RESEARCH, 2017, 14 (11) : 1138 - 1139
  • [9] Muscarinic agonists in Alzheimer's disease
    Growdon, JH
    LIFE SCIENCES, 1997, 60 (13-14) : 993 - 998
  • [10] The Lymphatic System In The Brain Clearance Mechanisms-New Therapeutic Perspectives For Alzheimer's Disease
    Chachaj, Angelika
    Gasiorowski, Kazimierz
    Szuba, Andrzej
    Sieradzki, Adrian
    Leszek, Jerzy
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (02) : 380 - 391